Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name YH003
Trade Name
Synonyms YH-003|YH 003
Drug Descriptions

YH003 is an anti-CD40 agonist antibody that activates CD40 signaling, which may lead to enhanced anti-tumor immune response (J Clin Oncol 39, no. 15_suppl (May 20, 2021) 2580-2580).

DrugClasses CD40 Antibody 13
CAS Registry Number NA
NCIT ID C178347


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Gemcitabine + Nab-paclitaxel + Toripalimab + YH003 Gemcitabine Nab-paclitaxel Toripalimab YH003 0 1
Pembrolizumab + YH001 + YH003 Pembrolizumab YH001 YH003 0 1
Toripalimab + YH003 Toripalimab YH003 0 1
YH003 YH003 0 0

Additional content available in CKB BOOST